Incannex Healthcare (IXHL) Stock Forecast: StockMap's 2-Week Call
IXHL stock forecast: StockMap's model makes no two-week call on Incannex Healthcare after the Nov 19 close: its evidence is split, 5 reasons for and 10 against. Right in 5 of 5 two-week windows on IXHL since Aug 21; by chance, a call on the same dates was right 64% of the time.
Incannex Healthcare last closed at $1.74, -0.57% on the session.
Against the IVW growth benchmark the position is +1.76% over the forecast window.
Incannex Healthcare's market cap is $21.83M as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -15 (too close to call).
Where IXHL sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 5 bullish and 10 bearish.
Agreement across those insights is 67%.
39 daily calls for IXHL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Incannex Healthcare in the 25th percentile on return on equity, where 100 is best.
Incannex Healthcare is classified under Health Care / Pharmaceuticals.
StockMap tracks Incannex Healthcare as the 122nd largest of the 153 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.
Across that group the current two-week reads are 80 Moderate Underperform, 44 Neutral and 29 Strong Underperform.
On that composite Incannex Healthcare ranks 37th of 153 in the group, against a group median of -0.36.